Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00246363
What this trial is testing

A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C

Who this might be right for
HIV InfectionsHepatitis C
Henry Sacks 40
Post-approval studies (Phase 4)UnknownNCT05085145
What this trial is testing

Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV

Who this might be right for
People Living With HIVCOVID-19Vaccine
Beijing 302 Hospital 200
Not applicableUnknownNCT06279819
What this trial is testing

Effectiveness of Gut Microbiota-targeted Dietary Intervention Among HIV-infected Patients

Who this might be right for
HivCardiovascular DiseasesDiet, Healthy
Fudan University 106
Not applicableStudy completedNCT00000719
What this trial is testing

A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Post-approval studies (Phase 4)Study completedNCT01866267
What this trial is testing

Switching Undetectables to Selzentry

Who this might be right for
Human Immunodeficiency VirusAIDS
St. Hope Foundation 31
Testing effectiveness (Phase 2)Study completedNCT03304093
What this trial is testing

Immunotherapy by Nivolumab for HIV+ Patients

Who this might be right for
Non Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer Stage IIIBHIV/AIDS
Intergroupe Francophone de Cancerologie Thoracique 30
Testing effectiveness (Phase 2)Study completedNCT00001114
What this trial is testing

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Study completedNCT00002009
What this trial is testing

A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

Who this might be right for
HIV InfectionsCytopenias
Sandoz
Not applicableStudy completedNCT00386971
What this trial is testing

Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART

Who this might be right for
HyperlipidemiaHIV Infections
University of California, Davis 13
Testing effectiveness (Phase 2)Study completedNCT00080106
What this trial is testing

Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114
Testing effectiveness (Phase 2)Study completedNCT00976404
What this trial is testing

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir

Who this might be right for
HIV Infection
Robert L. Murphy 28
Not applicableStudy completedNCT01917994
What this trial is testing

Text Messaging Intervention to Improve Retention in Care and Virologic Suppression in an Urban HIV-Infected Population

Who this might be right for
HIVPatient AdherenceMobile Technology
University of California, San Francisco 230
Testing effectiveness (Phase 2)Study completedNCT00196586
What this trial is testing

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Who this might be right for
HIV InfectionsChronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 75
Large-scale testing (Phase 3)Ended earlyNCT03333083
What this trial is testing

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen

Who this might be right for
HIV SeropositivityHIV InfectionsHIV-1-infection
Judit Pich 17
Not applicableStudy completedNCT00006441
What this trial is testing

Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 398
Not applicableStudy completedNCT00016783
What this trial is testing

Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 39
Not applicableNot Yet RecruitingNCT07146529
What this trial is testing

Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis

Who this might be right for
HIV SeropositivityHIV Drug ResistanceHIV Infections
ANRS, Emerging Infectious Diseases 30,060
Large-scale testing (Phase 3)WithdrawnNCT00476983
What this trial is testing

Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg

Who this might be right for
Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID
The HIV Netherlands Australia Thailand Research Collaboration
Testing effectiveness (Phase 2)Ended earlyNCT00432419
What this trial is testing

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

Who this might be right for
HIV InfectionsLymphoma, Non-Hodgkin
French National Agency for Research on AIDS and Viral Hepatitis 1
Large-scale testing (Phase 3)WithdrawnNCT00011128
What this trial is testing

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Next Page